Neuroproof GmbH of Rostock/Germany (www.neuroproof.com) presented on a journey to Israel its screening technology, which is used for preclinical development of neuroactive drugs and safety pharmacology, to selected Israeli biotech companies. This visit to initiate possible alliances and cooperation’s between Neuroproof and Israeli biotech companies was conceptually projected and accomplished by Brinkhaus Life Science Consulting of Hildesheim/Germany (www.biotech-alliances.com). Dr. Olaf Schroeder, Managing Director of Neuroproof, commented: “The cooperation with Brinkhaus Life Science Consulting gave us the opportunity to present our screening technology to Israeli biotech companies. We gladly took this opportunity and we are looking forward to possible cooperation’s with those Israeli biotech companies we had promising discussions with”.
Brinkhaus Life Science Consulting, a Germany based life science consultancy which concentrates on the initiation of alliances and collaborations between life science companies, provided the partnering concept and accomplished this visit. Dr. Frank Brinkhaus, Director of Brinkhaus Life Science Consulting: „ Neuroproof GmbH is a young biotech company with a very interesting screening technology. It was with great delight that we introduced Neuroproof GmbH to selected Israeli biotech companies”. NeuroProof GmbH offers screening services which analyse and clarify the complex effect of substances on the function of the brain and the whole central nervous system. The effect of potential medications on the CNS and possible neuro-toxic effects can be predicted early by means of these results. Thus it is possible to considerably accelerate the pre-clinical development of CNS drugs through additional generated information and to cut down on costs. Only few enterprises throughout the world are able to cultivate primary neuron/glia-cocultures on MEA-neuro-chips and are currently offering it. Through this technology the specific nervous tissue taken from foetal mice can be kept alive for days and weeks. MEA-neuro-chips record the electronic patterns of action potentials of single neurons in the complex network which can be interpreted afterwards. The effect of CNS drugs can be examined directly which was not previously possible.
Brinkhaus Life Science Consulting is management consulting firm engaged exclusively in the life science industry. Brinkhaus Life Science Consulting assists European and overseas life science companies in their aims to develop and to internalize their business and research activities through international alliances and collaborations. Brinkhaus Life Science projects and provides partnering concepts and frameworks and accompanies its clients through all phases of alliance and collaboration projects to final accomplishment. Brinkhaus Life Science Consulting has developed specific partnering services and operates www.biotech-alliances.com as a contact, dialogue and partnering platform.
NeuroProof GmbH Dr. Olaf Schroeder Dr. Alexandra Gramowski Friedrich-Barnewitz-Str. 4 18119 Rostock Germany Phone: +49+381.54345.660 Fax: +49+381.54345.661 E-Mail: info@neuroproof.com VAT-ID.: DE 252 753 013 Brinkhaus Life Science Consulting Dr. Frank Brinkhaus Koenigstrasse 13 D 31139 Hildesheim Germany Phone: +49+5121.6966.560 Fax: +49+5121.6966.558 E-Mail: mail@biotech-alliances.com VAT-ID.:DE 242 387 288
